


Tesamorelin
<p> Tesamorelin is a synthetic growth hormone releasing hormone analogue commonly researched for growth hormone signalling pathways, IGF-1 modulation models, metabolic regulation investigations, and peptide-based endocrine research applications. </p> <p> Research involving Tesamorelin has explored pulsatile growth hormone release dynamics, body composition pathway investigations, visceral fat signalling models, recovery-focused peptide studies, and metabolic optimisation research under controlled laboratory conditions. </p> <p> Tesamorelin peptide research is frequently associated with growth hormone secretagogue studies, recovery optimisation models, metabolic pathway investigations, performance-focused peptide research, and advanced endocrine signalling applications. </p> <p> This Vital Edge Science batch features Janoshik-verified Tesamorelin with a reported purity of 99.600% and independently verified analytical testing. </p> <p> Recommended for reconstitution using bacteriostatic water within controlled laboratory preparation environments. </p> <p> Each vial contains 10mg of high-purity lyophilised Tesamorelin intended strictly for analytical, laboratory, and scientific research applications. </p> <p> <strong>For research use only. Not for human consumption.</strong> </p>
Available variants
Product description
Product Overview
Tesamorelin is a synthetic growth hormone releasing hormone analogue supplied by Vital Edge Science for laboratory research involving growth hormone signalling, IGF-1 modulation, metabolic regulation, recovery pathways, and endocrine system investigations. This batch features independent Janoshik verification and Australia/New Zealand fulfilment support.
Available Formats
- 10mg × 1 vial
- 10mg × 10 vials
- MOQ: 1 vial
- Australia / New Zealand fulfilment
Batch Verification
- Purity: 99.600%
- Tested: 20 OCT 2025
- Task Number: #84093
- Verification Key: 4HFT88W8WIBT
Research Applications
- Growth hormone signalling research
- IGF-1 pathway investigations
- Metabolic regulation studies
- Recovery optimisation models
- Endocrine system research
Verification report

